Literature DB >> 6235995

Experimental glomerulonephritis induced by human IgG in rats.

K Yamamoto, T Oite, I Kihara, F Shimizu.   

Abstract

Experimental immune complex glomerulonephritis was induced with human IgG (HIgG) in two strains of rats, Wistar-King-Aptekman (WKA) and spontaneously hypertensive rats (SHR). The rats were pre-immunized s.c. with 1 mg of HIgG in Freund's complete adjuvant, and 8 weeks later were given a daily i.v. 2 mg of HIgG injections for 4 weeks. Renal tissue, obtained at weekly intervals after the beginning of i.v. injections, was examined by light, immunofluorescence and electron microscopic tests. SHR developed an endocapillary proliferative glomerulonephritis with heavy proteinuria after the administration of HIgG for 4 weeks. They had massive depositions of HIgG, rat IgG, and rat C3 both in the mesangial area and along the capillary wall. On the other hand, in WKA rats, the proliferative lesions were scarcely seen and the immune deposits were observed almost exclusively in the mesangium. Moreover, urinary protein excretion of these rats was within normal range. In comparison with bovine serum albumin (BSA) nephritis in SHR, HIgG-induced glomerular lesion was relatively mild. This difference seemed attributable to the nature of the HIgG, such as its molecular weight and immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235995      PMCID: PMC1536260     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Experimental chronic serum sickness in rats. A model of immune complex glomerulonephritis and systemic immune complex deposition.

Authors:  L Arisz; B Noble; M Milgrom; J R Brentjens; G A Andres
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

2.  Chronic immune complex disease in mice: the role of antibody affinity.

Authors:  M W Steward
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

3.  Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the chronic BSA-rabbit system.

Authors:  F G Germuth; L B Senterfit; G R Dreesman
Journal:  Johns Hopkins Med J       Date:  1972-06

4.  A unique influence of cortisone on the transit of specific macromolecules across vascular walls in immune complex disease.

Authors:  F G Germuth; A J Valdes; L B Senterfit; A D Pollack
Journal:  Johns Hopkins Med J       Date:  1968-03

5.  Properties of soluble immune complexes.

Authors:  R W Lightfoot; R E Drusin; C L Christian
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

6.  Experimental glomerulonephritis in rats.

Authors:  R H Fennell; V M Pardo
Journal:  Lab Invest       Date:  1967-11       Impact factor: 5.662

7.  Hypertensive changes in experimental nephritis combined with experimental hypertension.

Authors:  Y Masuyama; I Nishio; K Motoki; Y Kusuyama; S Tanaka
Journal:  Contrib Nephrol       Date:  1977       Impact factor: 1.580

8.  Impaired mesangial clearance of macromolecules in rats with chronic mesangial ferritin-antiferritin immune complex deposition.

Authors:  W F Keane; L Raij
Journal:  Lab Invest       Date:  1980-12       Impact factor: 5.662

9.  Bovine serum albumin (BSA) nephritis in rats. I. Experimental model.

Authors:  T Yamamoto; I Kihara; T Morita; T Oite
Journal:  Acta Pathol Jpn       Date:  1978-11

10.  Influence of hypertension on the progression of experimental autologous immune complex nephritis.

Authors:  S Okuda; K Onoyama; S Fujimi; Y Oh; K Nomoto; T Omae
Journal:  J Lab Clin Med       Date:  1983-03
View more
  1 in total

1.  Vascular Hyperactivity in the Rat Renal Aorta Participates in the Association between Immune Complex-Mediated Glomerulonephritis and Systemic Hypertension.

Authors:  Israel Pérez-Torres; Bernardo Moguel-González; Elizabeth Soria-Castro; Verónica Guarner-Lans; María Del Carmen Avila-Casado; Teresa Imelda Fortoul Vander Goes
Journal:  Int J Environ Res Public Health       Date:  2018-06-03       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.